...
首页> 外文期刊>Journal of Traditional and Complementary Medicine >Evaluation of in?vitro and in?vivo antileishmanial potential of bergenin rich Bergenia ligulata (Wall.) Engl. root extract against visceral leishmaniasis in inbred BALB/c mice through immunomodulation
【24h】

Evaluation of in?vitro and in?vivo antileishmanial potential of bergenin rich Bergenia ligulata (Wall.) Engl. root extract against visceral leishmaniasis in inbred BALB/c mice through immunomodulation

机译:富含降钙素的 Bergenia ligulata 体外体内抗疟药潜力的评估(墙。)免疫调节对近交BALB / c小鼠内脏利什曼病的根提取物

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Medicinal plants with immunomodulatory properties can provide good alternative therapeutics for curing visceral leishmaniasis. Bergenia ligulata (Wall.) Engl. is an interesting plant with strong antioxidant, antimicrobial, immunomodulatory and hepatoprotective properties. Aim The present study was planned to determine the antileishmanial activity of plant extract by modulating the immune responses of inbred BALB/c mice. Methodology Bergenin, the principle active component of B.?ligulata , was quantitated in crude extract by performing RP-HPLC. The therapeutic potential was assessed through in?vitro antileishmanial activity and in mice model through parasite load, cytokine assays, IgG antibody levels, DTH responses, histopathology and biochemical enzyme assays. Results B.?ligulata showed the presence of glycosides, saponins, carbohydrates, tannins, flavonoids and bergenin which contributed to the antileishmanial activity of extract with IC50 of 22.70?μg/mL. Furthermore, the higher dose significantly reduced the parasite load by 95.56 %. The reduction was further associated with significant enhancement of IL-12 and IFN-γ levels in comparison to IL-10 and IL-4 cytokines. The switching towards Th1 type of immune response was also confirmed by elevated antibody levels of IgG2a isotype as compared to IgG1 as well as increased DTH responses. The histology of liver and kidney further complimented the non toxic nature of plant extract in addition to its negligible toxicity on HeLa cells. Conclusions The current study revealed the significant antileishmanial and immunomodulatory properties of this plant extract against murine visceral leishmaniasis. Further, the bioactive components will be explored to assess their efficacy for the development of safe and cost effective drug. Graphical abstract Display Omitted.
机译:背景技术具有免疫调节特性的药用植物可以为内脏利什曼病的治疗提供良好的替代疗法。 Bergenia ligulata(墙)。是一种有趣的植物,具有很强的抗氧化剂,抗菌剂,免疫调节剂和保肝作用。目的本研究计划通过调节近交BALB / c小鼠的免疫应答来确定植物提取物的抗疟疾活性。方法学通过进行RP-HPLC定量测定粗提物中的B.?ulculata的主要活性成分Bergenin。通过体外抗疟疾活性评估治疗潜力,并通过寄生虫负荷,细胞因子检测,IgG抗体水平,DTH反应,组织病理学和生化酶检测评估小鼠模型。结果B.?ulculata表现出糖苷,皂角苷,碳水化合物,单宁,类黄酮和Bergenin的存在,这有助于提取物的抗菌活性,IC50为22.70μg/ mL。此外,较高剂量显着降低了95.56%的寄生虫负荷。与IL-10和IL-4细胞因子相比,该降低还与IL-12和IFN-γ水平的显着提高有关。与IgG1相比,IgG2a同种型的抗体水平升高以及DTH应答增加也证实了向Th1型免疫应答的转变。肝脏和肾脏的组织学除了对HeLa细胞的毒性可忽略不计外,还进一步补充了植物提取物的无毒性质。结论当前的研究揭示了这种植物提取物对鼠内脏利什曼病的显着的抗鼠疫和免疫调节特性。此外,将探索生物活性成分以评估其对开发安全且具有成本效益的药物的功效。图形抽象显示被忽略。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号